Supporting safe practices for low-dose methotrexate – NMS 2021
Inconsistent practices and information about the use of low-dose methotrexate for inflammatory diseases results in unfounded patient and health professional…
Inconsistent practices and information about the use of low-dose methotrexate for inflammatory diseases results in unfounded patient and health professional…
Poster presentation at SHPA Medicines Management Conference 2015 aiming to describe the decision-making process for access to High Cost Medicines…
Poster presentation at SHPA Medicines Management Conference 2015. This poster aims to provide guidance for good governance and decision-making in…
Editorial article in the Internal Medicine Journal 2015
Poster presentation at ASCEPT conference in 2013. CATAG developed a consensus framework to support the quality use of off-label medicines…
Poster presentation at SHPA conference 2013. Aims to provide a snapshot of the extent of off-label rituximab use.
Poster presentation at SHPA Medicines Management Conference 2013
Poster presentation at SHPA Medicines Management Conference 2013.
Original article in the Internal Medicine Journal 2013 on off-label use of rituximab in Australian public hospitals.